HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosa Marina Melillo Selected Research

Multiple Endocrine Neoplasia Type 2b (MEN 3)

1/2018RET-mediated modulation of tumor microenvironment and immune response in multiple endocrine neoplasia type 2 (MEN2).
6/2006The receptor-type protein tyrosine phosphatase J antagonizes the biochemical and biological effects of RET-derived oncoproteins.
6/2002Molecular mechanisms of RET activation in human cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosa Marina Melillo Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 06/2002
18Thyroid Neoplasms (Thyroid Cancer)
06/2019 - 06/2004
9Papillary Thyroid Cancer
11/2011 - 04/2003
5Inflammation (Inflammations)
02/2021 - 01/2012
3Multiple Endocrine Neoplasia Type 2a (MEN 2)
01/2018 - 05/2003
3Multiple Endocrine Neoplasia Type 2b (MEN 3)
01/2018 - 06/2002
2Stomach Neoplasms (Stomach Cancer)
02/2021 - 01/2017
2Thymoma (Thymic Carcinoma)
06/2019 - 09/2005
2Neoplasm Metastasis (Metastasis)
01/2017 - 01/2012
2Carcinoma (Carcinomatosis)
08/2010 - 11/2005
1Microsatellite Instability
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
01/2022
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis)
01/2018
1Porcine Reproductive and Respiratory Syndrome (PRRS)
12/2015
1Anaplastic Thyroid Carcinoma
05/2014
1Pulmonary Arterial Hypertension
09/2013
1Adenoma (Adenomas)
11/2011
1Neuroblastoma
01/2007
1Sarcoma (Soft Tissue Sarcoma)
01/2007
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2005
1medullary Thyroid cancer
04/2003
1Breast Neoplasms (Breast Cancer)
10/2002
1Papillary Carcinoma
06/2002

Drug/Important Bio-Agent (IBA)

9Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2019 - 06/2002
6LigandsIBA
01/2021 - 08/2004
6Phosphotransferases (Kinase)IBA
03/2011 - 06/2002
5Oncogene Proteins (Oncogene Protein)IBA
01/2007 - 06/2002
4Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
01/2022 - 12/2015
4Proteins (Proteins, Gene)FDA Link
05/2010 - 06/2002
3Chemokine ReceptorsIBA
01/2012 - 08/2004
3Chemokine CXCL12IBA
03/2011 - 08/2004
3Biological ProductsIBA
07/2008 - 08/2004
2Pattern Recognition ReceptorsIBA
02/2021 - 12/2015
2IodineIBA
06/2019 - 12/2017
2LipoxygenasesIBA
01/2018 - 01/2017
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2018 - 01/2017
2Interleukin-8 (Interleukin 8)IBA
05/2017 - 01/2017
2Tyrosine (L-Tyrosine)FDA Link
03/2011 - 05/2003
2matrigelIBA
11/2005 - 09/2005
2OsteopontinIBA
11/2005 - 09/2005
2Cyclin-Dependent Kinase Inhibitor p27IBA
06/2004 - 10/2002
1B7-H1 AntigenIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022
1NivolumabIBA
01/2022
1Toll-Like Receptor 7IBA
02/2021
1NF-kappa B (NF-kB)IBA
06/2019
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
01/2018
1EnzymesIBA
01/2018
1Interleukin-8A Receptors (Receptors, Interleukin 8A)IBA
05/2017
1reparixinIBA
05/2017
1Chemokine CXCL1IBA
01/2017
1ChemokinesIBA
01/2017
1Chemokine CXCL6IBA
01/2017
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
05/2014
1Messenger RNA (mRNA)IBA
05/2014
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2014
1Conditioned Culture MediaIBA
05/2014
1KynurenineIBA
05/2014
1Interleukin-33IBA
09/2013
1Tryptases (Tryptase)IBA
11/2011
1tyrosine receptor (receptor, tyrosine)IBA
03/2011
1Small Interfering RNA (siRNA)IBA
03/2011
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2010
1Monoclonal AntibodiesIBA
05/2010
1Galectin 3 (LGALS3)IBA
05/2010
1CXCR4 Receptors (CXCR4 Receptor)IBA
05/2010
1DisulfidesIBA
07/2008
1plerixaforFDA Link
12/2007
1Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
01/2007
1Carrier Proteins (Binding Protein)IBA
01/2007
1Growth Factor ReceptorsIBA
01/2007
1Monomeric GTP-Binding ProteinsIBA
01/2007
1Sorafenib (BAY 43-9006)FDA Link
03/2006
1Urea (Carbamide)FDA LinkGeneric
03/2006
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
11/2005
1CytokinesIBA
11/2005
1Mitogen-Activated Protein KinasesIBA
11/2005
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
09/2005
1Glycoproteins (Glycoprotein)IBA
09/2005
1vandetanib (ZD6474)IBA
06/2004
1pyrimidineIBA
04/2003
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2002
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2002

Therapy/Procedure

5Therapeutics
01/2022 - 05/2010
2Immunotherapy
01/2022 - 01/2019
1Thyroidectomy
08/2010
1Radiotherapy
12/2007
1Drug Therapy (Chemotherapy)
12/2007